When it comes to menopause, facts are better than fears. In our collaboration with @_backtableobgyn, @DrRachelRubin joins @SuzetteESutherl to discuss hormone replacement therapy and better supporting menopausal patients with evidence-based care #URO258.

Intermediate-risk bladder cancer is often overlooked in research and clinical discussions. Dr. Kelly Bree highlights the importance of studying patient-reported outcomes and patient treatment priorities in intermediate-risk bladder cancer, especially as new intravesical agents

RT @TylerSbrt: Fun chatting with @neerajaiims and @marthpodi about #ProstateCancer on @_backtableUro . AS, #radonc, PSMA PET, molecular / g….

How can residents prepare not only for clinical practice, but also for financial stability? @RoboUroMD joins @GMBadalato to share strategies on budgeting, debt management, and investing for young physicians #URO257.

In-office fulguration can be a well-tolerated option for select bladder cancer patients. Dr. Kelly Bree outlines her clinical criteria for offering in-office treatment, typically for patients with low-grade tumors under 1 cm, and highlights the importance of individualized

RT @lindsayahampson: So fun to record this episode on a really important topic that is under-recognized and we need to talk more about!. @U….

RT @drjkaouk: Cleveland Clinic Florida Urology @PierettiAlberto discusses bladders cancer management. Very informative! @CleClinicUro.

Could ctDNA testing allow us to treat bladder cancer earlier, smarter, and more effectively? @PierettiAlberto joins @drjesilva to explore ctDNA as an emerging tool in bladder cancer management #URO256.

RT @m_e_nielsen: @_backtableUro @mvankuikenmd @lindsayahampson Awesome episode! Love the idea of making friends w your imposter 🤓 https://….

Imposter syndrome is more common in medicine than we admit. @mvankuikenmd joins @lindsayahampson to discuss how self-doubt shapes training and practice - and how reframing, mentorship, and openness can turn it into growth #URO255.

Setting expectations is key when preparing patients for TURBT in intermediate-risk bladder cancer. Dr. Kelly Bree shares her preoperative counseling approach, including guidance on catheter use, expected urinary symptoms, and advance prescriptions for medications like Levcin and

RT @RuchikaTalwarMD: Wrapping up our first @_backtableUro #CreatorWeekend in sunny San Diego!! ☀️🌊🌴. Recording insightful discussions on #N….

Our @_backtableUro team is up to something exciting this weekend 👀. Here’s a sneak peek of our first #CreatorWeekend on #NMIBC in San Diego! 🌴. Stay tuned for more behind the scenes footage 🎥

How do you prepare patients with intermediate-risk bladder cancer for the long-term realities of their diagnosis? Dr. Kelly Bree discusses the importance of quality-of-life counseling for these patients who face frequent procedures and ongoing surveillance, highlighting the

RT @AmyPearlman1: Just dropped a 🔥 episode of @_backtableUro with @DrVondaWright .She founded PRIMA to prove aging isn’t a downhill slide.….

RT @AmyPearlman1: Ages 35–45 = the critical decade. You’re stable socially. You’re earning your own $. Your hormones + stem cells are still….

How do you treat bladder cancer when BCG is in short supply? @AmyLuckenbaugh joins @RuchikaTalwarMD to discuss coping strategies, alternative intravesical therapies, and emerging treatments for high-risk patients #URO253.

How should we approach risk stratification for patients with intermediate-risk NMIBC? Dr. Kelly Bree shares her clinical framework for identifying intermediate-risk bladder cancer and explains how her approach differs from guideline definitions. She also discusses opportunities

Orthopedics meets urology: @DrVondaWright joins @AmyPearlman1 to explore the role of longevity-focused strategies - exercise, nutrition, and empathy - in optimizing surgical recovery and patient care #URO252.

RT @AmyPearlman1: If I could have dinner with anyone—dead or alive—it would be @DrMorgentaler (who is very much alive). On the latest @_bac….